Skip to main content
SpringerLink
Log in

Who should use recombinant factor VIII?

  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Gulf States Hemophilia Diagnostic and Treatment Center, University of Texas, Health Science Center, 6410 Fanin Street, Suite 416, 77030, Houston, TX, USA

    K. Hoots

Authors
  1. K. Hoots
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoots, K. Who should use recombinant factor VIII?. Ann Hematol 68 (Suppl 3), S65–S68 (1994). https://doi.org/10.1007/BF01774538

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01774538

Keywords

Search

Navigation